Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) · filed Nov 19, 2025
- Accession no.
- 0001193125-25-288284
- Filed
- Nov 19, 2025, 5:02 PM ET
- Trade date
- Nov 19, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions. Open-market purchases total $759.1K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | Common Stock | PPurchaseAcquired | +36,325 | $1.28 | +$46,496 | 215,002,773 | Indirect | |
| Nov 19, 2025 | Common Stock | PPurchaseAcquired | +58,160 | $1.29 | +$74,735.6 | 215,060,933 | Indirect | |
| Nov 19, 2025 | Common Stock | PPurchaseAcquired | +300 | $1.29 | +$387 | 215,061,233 | Indirect | |
| Nov 19, 2025 | Common Stock | PPurchaseAcquired | +21,236 | $1.30 | +$27,500.62 | 215,082,469 | Indirect | |
| Nov 19, 2025 | Common Stock | PPurchaseAcquired | +30,082 | $1.30 | +$39,106.6 | 215,112,551 | Indirect | |
| Nov 19, 2025 | Common Stock | PPurchaseAcquired | +12,993 | $1.31 | +$16,955.87 | 215,125,544 | Indirect | |
| Nov 19, 2025 | Common Stock | PPurchaseAcquired | +66,504 | $1.31 | +$87,120.24 | 215,192,048 | Indirect | |
| Nov 19, 2025 | Common Stock | PPurchaseAcquired | +198,904 | $1.32 | +$261,558.76 | 215,390,952 | Indirect | |
| Nov 19, 2025 | Common Stock | PPurchaseAcquired | +155,496 | $1.32 | +$205,254.72 | 215,546,448 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.